(MPLX) MPLX - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US55336V1008
Stock: Oil, Gas, Liquids, Terminals, Transport
Total Rating 45
Risk 61
Buy Signal -0.19
| Risk 5d forecast | |
|---|---|
| Volatility | 13.9% |
| Relative Tail Risk | -1.80% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.88 |
| Alpha | 9.45 |
| Character TTM | |
|---|---|
| Beta | 0.360 |
| Beta Downside | 0.488 |
| Drawdowns 3y | |
|---|---|
| Max DD | 14.58% |
| CAGR/Max DD | 2.13 |
EPS (Earnings per Share)
Revenue
Description: MPLX MPLX March 04, 2026
MPLX LP is a US-based midstream energy company. It primarily operates crude oil and products logistics, alongside natural gas and NGL services. Midstream companies typically focus on transportation and processing rather than exploration or refining.
The companys operations include gathering, processing, and transporting natural gas, NGLs, crude oil, and refined products. It also manages marine transportation and terminal facilities. This infrastructure is crucial for moving energy resources from production sites to refineries and end-users.
MPLX LP is a subsidiary of Marathon Petroleum Corporation. Further research on ValueRay can provide detailed financial metrics and operational data for MPLX LP.
Headlines to watch out for
- Crude oil and natural gas prices impact segment profitability
- Regulatory changes to pipeline operations increase compliance costs
- Demand for refined products affects logistics and storage revenue
- Interest rate fluctuations influence debt servicing costs
- Expansion projects drive future revenue growth and capital expenditures
Piotroski VR‑10 (Strict, 0-10) 5.5
| Net Income: 4.91b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.14 > 0.02 and ΔFCF/TA 0.70 > 1.0 |
| NWC/Revenue: 6.01% < 20% (prev 0.38%; Δ 5.64% < -1%) |
| CFO/TA 0.14 > 3% & CFO 5.91b > Net Income 4.91b |
| Net Debt (24.02b) to EBITDA (7.32b): 3.28 < 3 |
| Current Ratio: 1.23 > 1.5 & < 3 |
| Outstanding Shares: last quarter (1.02b) vs 12m ago -0.20% < -2% |
| Gross Margin: 49.69% > 18% (prev 0.44%; Δ 4.92k% > 0.5%) |
| Asset Turnover: 30.78% > 50% (prev 29.07%; Δ 1.71% > 0%) |
| Interest Coverage Ratio: 5.85 > 6 (EBITDA TTM 7.32b / Interest Expense TTM 1.02b) |
Altman Z''
| A: 0.02 (Total Current Assets 3.99b - Total Current Liabilities 3.25b) / Total Assets 43.01b |
| B: error (Retained Earnings missing) |
| C: 0.15 (EBIT TTM 5.97b / Avg Total Assets 40.26b) |
| D: 0.50 (Book Value of Equity 14.30b / Total Liabilities 28.48b) |
Beneish M -3.10
| DSRI: 0.94 (Receivables 1.64b/1.54b, Revenue 12.39b/10.90b) |
| GMI: 0.89 (GM 49.69% / 44.18%) |
| AQI: 1.00 (AQ_t 0.39 / AQ_t-1 0.39) |
| SGI: 1.14 (Revenue 12.39b / 10.90b) |
| TATA: -0.02 (NI 4.91b - CFO 5.91b) / TA 43.01b) |
| Beneish M-Score: -3.10 (Cap -4..+1) = AA |
What is the price of MPLX shares?
As of March 16, 2026, the stock is trading at USD 58.52 with a total of 1,680,310 shares traded.
Over the past week, the price has changed by +0.57%, over one month by +2.04%, over three months by +8.68% and over the past year by +15.85%.
Over the past week, the price has changed by +0.57%, over one month by +2.04%, over three months by +8.68% and over the past year by +15.85%.
Is MPLX a buy, sell or hold?
MPLX has received a consensus analysts rating of 3.80.
Therefor, it is recommend to hold MPLX.
- StrongBuy: 4
- Buy: 5
- Hold: 5
- Sell: 1
- StrongSell: 0
What are the forecasts/targets for the MPLX price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 58 | -0.9% |
| Analysts Target Price | 58 | -0.9% |
MPLX Fundamental Data Overview March 14, 2026
P/E Trailing = 12.1079
P/E Forward = 12.1655
P/S = 5.0229
P/B = 4.1429
P/EG = 3.3132
Revenue TTM = 12.39b USD
EBIT TTM = 5.97b USD
EBITDA TTM = 7.32b USD
Long Term Debt = 24.15b USD (from longTermDebt, last quarter)
Short Term Debt = 1.56b USD (from shortTermDebt, last quarter)
Debt = 26.16b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 24.02b USD (from netDebt column, last quarter)
Enterprise Value = 83.38b USD (59.36b + Debt 26.16b - CCE 2.14b)
Interest Coverage Ratio = 5.85 (Ebit TTM 5.97b / Interest Expense TTM 1.02b)
EV/FCF = 14.11x (Enterprise Value 83.38b / FCF TTM 5.91b)
FCF Yield = 7.09% (FCF TTM 5.91b / Enterprise Value 83.38b)
FCF Margin = 47.69% (FCF TTM 5.91b / Revenue TTM 12.39b)
Net Margin = 39.64% (Net Income TTM 4.91b / Revenue TTM 12.39b)
Gross Margin = 49.69% ((Revenue TTM 12.39b - Cost of Revenue TTM 6.23b) / Revenue TTM)
Gross Margin QoQ = 47.30% (prev 60.82%)
Tobins Q-Ratio = 1.94 (Enterprise Value 83.38b / Total Assets 43.01b)
Interest Expense / Debt = 1.06% (Interest Expense 277.0m / Debt 26.16b)
Taxrate = 0.25% (3.00m / 1.21b)
NOPAT = 5.96b (EBIT 5.97b * (1 - 0.25%))
Current Ratio = 1.23 (Total Current Assets 3.99b / Total Current Liabilities 3.25b)
Debt / Equity = 1.83 (Debt 26.16b / totalStockholderEquity, last quarter 14.30b)
Debt / EBITDA = 3.28 (Net Debt 24.02b / EBITDA 7.32b)
Debt / FCF = 4.07 (Net Debt 24.02b / FCF TTM 5.91b)
Total Stockholder Equity = 14.06b (last 4 quarters mean from totalStockholderEquity)
RoA = 12.20% (Net Income 4.91b / Total Assets 43.01b)
RoE = 34.93% (Net Income TTM 4.91b / Total Stockholder Equity 14.06b)
RoCE = 15.62% (EBIT 5.97b / Capital Employed (Equity 14.06b + L.T.Debt 24.15b))
RoIC = 15.72% (NOPAT 5.96b / Invested Capital 37.87b)
WACC = 5.35% (E(59.36b)/V(85.52b) * Re(7.24%) + D(26.16b)/V(85.52b) * Rd(1.06%) * (1-Tc(0.00)))
Discount Rate = 7.24% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 33.33 | Cagr: 0.70%
[DCF] Terminal Value 86.97% ; FCFF base≈5.50b ; Y1≈5.88b ; Y5≈7.10b
[DCF] Fair Price = 183.5 (EV 210.27b - Net Debt 24.02b = Equity 186.25b / Shares 1.02b; r=5.90% [WACC]; 5y FCF grow 7.63% → 2.90% )
EPS Correlation: 61.17 | EPS CAGR: 11.42% | SUE: 0.70 | # QB: 0
Revenue Correlation: 69.54 | Revenue CAGR: 5.87% | SUE: -2.53 | # QB: 0
EPS next Quarter (2026-06-30): EPS=1.08 | Chg7d=+0.000 | Chg30d=+0.012 | Revisions Net=+1 | Analysts=2
EPS current Year (2026-12-31): EPS=4.56 | Chg7d=+0.000 | Chg30d=-0.054 | Revisions Net=-1 | Growth EPS=+5.1% | Growth Revenue=+0.5%
EPS next Year (2027-12-31): EPS=4.91 | Chg7d=+0.000 | Chg30d=-0.013 | Revisions Net=+0 | Growth EPS=+7.8% | Growth Revenue=+6.8%
[Analyst] Revisions Ratio: +1.00 (1 Up / 0 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = -0.3% (Discount Rate 7.9% - Earnings Yield 8.3%)
[Growth] Growth Spread = +7.7% (Analyst 7.4% - Implied -0.3%)
P/E Forward = 12.1655
P/S = 5.0229
P/B = 4.1429
P/EG = 3.3132
Revenue TTM = 12.39b USD
EBIT TTM = 5.97b USD
EBITDA TTM = 7.32b USD
Long Term Debt = 24.15b USD (from longTermDebt, last quarter)
Short Term Debt = 1.56b USD (from shortTermDebt, last quarter)
Debt = 26.16b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 24.02b USD (from netDebt column, last quarter)
Enterprise Value = 83.38b USD (59.36b + Debt 26.16b - CCE 2.14b)
Interest Coverage Ratio = 5.85 (Ebit TTM 5.97b / Interest Expense TTM 1.02b)
EV/FCF = 14.11x (Enterprise Value 83.38b / FCF TTM 5.91b)
FCF Yield = 7.09% (FCF TTM 5.91b / Enterprise Value 83.38b)
FCF Margin = 47.69% (FCF TTM 5.91b / Revenue TTM 12.39b)
Net Margin = 39.64% (Net Income TTM 4.91b / Revenue TTM 12.39b)
Gross Margin = 49.69% ((Revenue TTM 12.39b - Cost of Revenue TTM 6.23b) / Revenue TTM)
Gross Margin QoQ = 47.30% (prev 60.82%)
Tobins Q-Ratio = 1.94 (Enterprise Value 83.38b / Total Assets 43.01b)
Interest Expense / Debt = 1.06% (Interest Expense 277.0m / Debt 26.16b)
Taxrate = 0.25% (3.00m / 1.21b)
NOPAT = 5.96b (EBIT 5.97b * (1 - 0.25%))
Current Ratio = 1.23 (Total Current Assets 3.99b / Total Current Liabilities 3.25b)
Debt / Equity = 1.83 (Debt 26.16b / totalStockholderEquity, last quarter 14.30b)
Debt / EBITDA = 3.28 (Net Debt 24.02b / EBITDA 7.32b)
Debt / FCF = 4.07 (Net Debt 24.02b / FCF TTM 5.91b)
Total Stockholder Equity = 14.06b (last 4 quarters mean from totalStockholderEquity)
RoA = 12.20% (Net Income 4.91b / Total Assets 43.01b)
RoE = 34.93% (Net Income TTM 4.91b / Total Stockholder Equity 14.06b)
RoCE = 15.62% (EBIT 5.97b / Capital Employed (Equity 14.06b + L.T.Debt 24.15b))
RoIC = 15.72% (NOPAT 5.96b / Invested Capital 37.87b)
WACC = 5.35% (E(59.36b)/V(85.52b) * Re(7.24%) + D(26.16b)/V(85.52b) * Rd(1.06%) * (1-Tc(0.00)))
Discount Rate = 7.24% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 33.33 | Cagr: 0.70%
[DCF] Terminal Value 86.97% ; FCFF base≈5.50b ; Y1≈5.88b ; Y5≈7.10b
[DCF] Fair Price = 183.5 (EV 210.27b - Net Debt 24.02b = Equity 186.25b / Shares 1.02b; r=5.90% [WACC]; 5y FCF grow 7.63% → 2.90% )
EPS Correlation: 61.17 | EPS CAGR: 11.42% | SUE: 0.70 | # QB: 0
Revenue Correlation: 69.54 | Revenue CAGR: 5.87% | SUE: -2.53 | # QB: 0
EPS next Quarter (2026-06-30): EPS=1.08 | Chg7d=+0.000 | Chg30d=+0.012 | Revisions Net=+1 | Analysts=2
EPS current Year (2026-12-31): EPS=4.56 | Chg7d=+0.000 | Chg30d=-0.054 | Revisions Net=-1 | Growth EPS=+5.1% | Growth Revenue=+0.5%
EPS next Year (2027-12-31): EPS=4.91 | Chg7d=+0.000 | Chg30d=-0.013 | Revisions Net=+0 | Growth EPS=+7.8% | Growth Revenue=+6.8%
[Analyst] Revisions Ratio: +1.00 (1 Up / 0 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = -0.3% (Discount Rate 7.9% - Earnings Yield 8.3%)
[Growth] Growth Spread = +7.7% (Analyst 7.4% - Implied -0.3%)